P
IHI icon

&Partners’s iShares US Medical Devices ETF IHI Stock Holding History

&Partners’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Buy
49,239
+382
+0.8% +$19.4K 0.01% 923
2026
Q1 		$2.61M Buy
48,857
+1,341
+3% +$78.7K 0.01% 791
2025
Q4 		$2.95M Buy
47,516
+6,107
+15% +$377K 0.02% 691
2025
Q3 		$2.49M Buy
41,409
+3,783
+10% +$231K 0.02% 671
2025
Q2 		$2.36M Buy
37,626
+5,102
+16% +$307K 0.02% 603
2025
Q1 		$1.93M Sell
32,524
-2,745
-8% -$171K 0.02% 552
2024
Q4 		$2.07M Buy
35,269
+17,248
+96% +$1.03M 0.02% 489
2024
Q3 		$1.07M Sell
18,021
-772
-4% -$44.1K 0.02% 556
2024
Q2 		$1.05M Buy
18,793
+2,469
+15% +$138K 0.05% 336
2024
Q1 		$956K Buy
16,324
+444
+3% +$25.1K 0.13% 158
2023
Q4 		$857K Hold
15,880
– – 0.21% 110
2023
Q3 		$770K Sell
15,880
-540
-3% -$28.7K 0.36% 57
2023
Q2 		$927K Sell
16,420
-935
-5% -$51.5K 0.42% 47
2023
Q1 		$937K Sell
17,355
-330
-2% -$17.6K 0.45% 44
2022
Q4 		$930K Sell
17,685
-1,169
-6% -$59.3K 0.46% 46
2022
Q3 		$890K Hold
18,854
– – 0.51% 45
2022
Q2 		$951K Sell
18,854
-299
-2% -$16.3K 0.55% 38
2022
Q1 		$1.17M Sell
19,153
-540
-3% -$32.2K 0.66% 26
2021
Q4 		$1.3M Hold
19,693
– – 0.78% 26
2021
Q3 		$1.24M Buy
19,693
+103
+0.5% +$6.57K 0.79% 31
2021
Q2 		$1.18M Sell
19,590
-390
-2% -$22.6K 0.76% 33
2021
Q1 		$1.1M Hold
19,980
– – 0.8% 32
2020
Q4 		$1.09M Buy
19,980
+420
+2% +$22K 0.92% 31
2020
Q3 		$977K Hold
19,560
– – 0.99% 30
2020
Q2 		$863K Buy
19,560
+540
+3% +$23.1K 1.04% 25
2020
Q1 		$714K Hold
19,020
– – 1.11% 21
2019
Q4 		$838K Sell
19,020
-270
-1% -$11.3K 1% 27
2019
Q3 		$795K Hold
19,290
– – 1.03% 22
2019
Q2 		$774K Hold
19,290
– – 1.07% 22
2019
Q1 		$744K Sell
19,290
-270
-1% -$9.8K 1.07% 26
2018
Q4 		$651K Buy
+19,560
New +$677K 1.09% 26

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

&Partners's IHI Position: Q2 2026 in Review

&Partners increased its iShares US Medical Devices ETF (IHI) stake by 0.78% in Q2 2026, buying an estimated $19.4K and bringing the position to 49,239 shares worth $2.44M. The position accounts for 0.01% of the portfolio, ranked #923.

&Partners first reported a position in IHI in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.95M in Q4 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • &Partners held 49,239 shares of iShares US Medical Devices ETF worth $2.44M as of Q2 2026.
  • &Partners bought 382 iShares US Medical Devices ETF shares in Q2 2026, an estimated $19.4K.
  • iShares US Medical Devices ETF made up 0.01% of &Partners's portfolio in Q2 2026, its #923 holding.
  • &Partners first reported a position in iShares US Medical Devices ETF in Q4 2018 and has held it in 31 quarters since.
  • &Partners's iShares US Medical Devices ETF position peaked at $2.95M in Q4 2025.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.